Howard I. Scher
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 10%
- Molecular Biology
- Radiology, Nuclear Medicine and Imaging top 10%
- Surgery
- Co-authors
- Ursula S. OfmanHarry W. HerrMadhu MazumdarWilliam Kevin KellyRobert F. RockwellNicholas A. GiorgioPatricia RockwellNeil I. Goldstein
- Topics
- Prostate Cancer Treatment and Research (9 papers)Cancer, Lipids, and Metabolism (3 papers)PARP inhibition in cancer therapy (3 papers)
- Partner nations
- United StatesSpain
In The Last Decade
Howard I. Scher
16 papers receiving 912 citations
Peers
Comparison fields: 5 of 103
- Oncology 481
- Pulmonary and Respiratory Medicine 341
- Molecular Biology 182
- Radiology, Nuclear Medicine and Imaging 124
- Surgery 118
Countries citing papers authored by Howard I. Scher
This map shows the geographic impact of Howard I. Scher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howard I. Scher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howard I. Scher more than expected).
Fields of papers citing papers by Howard I. Scher
This network shows the impact of papers produced by Howard I. Scher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howard I. Scher. The network helps show where Howard I. Scher may publish in the future.
Co-authorship network of co-authors of Howard I. Scher
This figure shows the co-authorship network connecting the top 25 collaborators of Howard I. Scher. A scholar is included among the top collaborators of Howard I. Scher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Howard I. Scher. Howard I. Scher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 95 | |
| 5 | The development of biologic end points in patients treated with differentiation agents: an experience of retinoids in prostate cancer. | 45 |
| 6 | 43 | |
| 7 | Interferon-gamma and monoclonal antibody 131I-labeled CC49: outcomes in patients with androgen-independent prostate cancer. | 54 |
| 8 | 1 | |
| 9 | 24 | |
| 10 | 95 | |
| 11 | 206 | |
| 12 | 279 | |
| 13 | 1 | |
| 14 | 9 | |
| 15 | 74 | |
| 16 | 2 | |
| 17 | Chemotherapy for invasive bladder cancer: neoadjuvant versus adjuvant. | 31 |
About Howard I. Scher
Howard I. Scher is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Behavioral Neuroscience, having authored 17 papers that have together received 961 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (9 papers), Cancer, Lipids, and Metabolism (3 papers) and PARP inhibition in cancer therapy (3 papers). The work is most often cited by research in Oncology (481 citations), Pulmonary and Respiratory Medicine (341 citations) and Radiology, Nuclear Medicine and Imaging (124 citations). Howard I. Scher has collaborated with scholars based in United States and Spain. Frequent co-authors include Ursula S. Ofman, Harry W. Herr, Madhu Mazumdar, William Kevin Kelly, Robert F. Rockwell, Nicholas A. Giorgio, Patricia Rockwell, Neil I. Goldstein, John Mendelsohn and Marie Prewett. Their work appears in journals such as JNCI Journal of the National Cancer Institute, Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.